ABBV-3067

ABBV-3067 · AbbVie

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABBV-3067, covering 2023-06-28 to 2023-06-28. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of ABBV-3067 Alone and in Combination With ABBV-2222 [Phase 2]